Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy

BACKGROUND: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related death worldwide. The majority of HCCs are diagnosed in a stage that is not eligible for curative resection. For intermediate stage HCC, transarterial chemoembolization (TACE) is the recommended treatment. We evalua...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Schicho, Andreas, Pereira, Philippe L., Haimerl, Michael, Niessen, Christoph, Michalik, Katharina, Beyer, Lukas P., Stroszczynski, Christian, Wiggermann, Philipp
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641156/
https://ncbi.nlm.nih.gov/pubmed/29069813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars